


I just heard from a friend that Archbishop Austin Randolph Adler passed away on December 9th (Obituary from Charisma News here). Here he is praying for me back in 1996 – when I was an Assemblies of God pastor discerning a call to the Priesthood.
Back in 1995, another pastor sent me a VHS tape of Archbishop Adler consecrating a bishop in the Philippines (this is what we had to do before there was YouTube!).
The video encapsulated the beautiful blending of sacramental, evangelical and charismatic traditions during the solemn consecration of Loren Thomas Hines to the Office of Bishop. At the time, I didn’t realize it, but this was exactly what I had been searching for spiritually — and Archbishop Adler helped make it all make sense.
Archbishop Adler demonstrated a fullness in the Holy Spirit in his ministry – blending the catholic, evangelical and charismatic / Pentecostal traditions. He was a worship leader in the truest sense in that he exuded joy during the music and fully inhabited the liturgy as the presider. Archbishop Adler invited full participation from the congregation as the celebrant and it was always a joy to be present when he was leading.
I hope that, after my over 20 years of service so far as a deacon, priest, and now as a bishop, I am honoring, in some small way, the spiritual seed Archbishop Adler sowed into my life.
I pray that this has not been in vain, as the vision God gave Archbishop Adler — and that he imparted to me — still lives in my heart: to see the three streams of historic Christianity — sacramental, evangelical, and charismatic / Pentecostal — flow together into one mighty river.
Archbishop Adler left an indelible mark on my ministry. I don’t think I would be a priest today without his prophetic teaching, which spoke powerfully into my life.
Rest in peace, Archbishop Randy. I thank God for bringing you into my life.





Dr. Lumanog is currently pursuing post-graduate studies in Management at Harvard University through the Harvard Extension School. He is an accomplished corporate strategist with extensive experience leading high-impact clinical projects for a Fortune 20 healthcare company.